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Ficus deltoidea from the Moraceae family has been scientiﬁcally proven to reduce hyperglycemia at diﬀerent prandial states. In
this study, we evaluate the mechanisms that underlie antihyperglycemic action of Ficus deltoidea. The results had shown that
hot aqueous extract of Ficus deltoidea stimulated insulin secretion signiﬁcantly with the highest magnitude of stimulation was
7.31-fold (P<0.001). The insulin secretory actions of the hot aqueous extract involved K
+
ATP channel-dependent and K
+
ATP-
channel-independent pathway. The extract also has the ability to induce the usage of intracellular Ca2+ to trigger insulin release.
The ethanolic and methanolic extracts enhanced basal and insulin-mediated glucose uptake into adipocytes cells. The extracts
possess either insulin-mimetic or insulin-sensitizing property or combination of both properties during enhancing glucose uptake
intosuchcells.Meanwhile,thehotaqueousandmethanolicextractsaugmentedbasalandinsulin-stimulatedadiponectinsecretion
fromadipocytescells.Fromthisstudy,itissuggestedthatFicusdeltoideahasthepotentialtobedevelopedasfutureoralantidiabetic
agent.
1.Introduction
Type 2 diabetes mellitus is characterized by persistent hyper-
glycemia resulting from defect of insulin secretion and
insulinaction[1].Long-termhyperglycemiaisamajorfactor
in development of pathogenesis of diabetic complications
[2, 3]. Currently, type 2 diabetes mellitus is treated with
antidiabetic agents such as sulphonylureas, meglitinides,
thiazolidinediones groups, and so forth. Although plenty of
antidiabetic agents are available, prevalence of the disease
remainsmajorglobalhealthproblem[4].Thiscouldpossibly
be due to the limitations of these agents such as undesirable
side eﬀects [5]. For instance, sulphonylureas treatment
was associated with hypoglycemia and weight gain [6–
8]. Meglitinides treatment causes hypoglycemia, rhinitis,
bronchitis, and headache [9]. Meanwhile, thiazolidinediones
can cause ﬂuid retention, weight gain, anemia, and liver
injury [10, 11]. These limitations have fueled the search for
new antidiabetic drugs for treatment of diabetes mellitus.
Stimulation of insulin secretion from pancreatic β cells
is one of the mechanisms by which antidiabetic agents
reduce hyperglycemia [12, 13]. The secreted insulin then
facilitates glucose uptake in insulin-sensitive cells such as
muscle, liver, and adipocytes, hence reduces hyperglycemia
[14]. Besides, augmentation of adiponectin secretion from
adipocytes cells also has been well accepted as antidiabetic
mechanism. This adipocyte-derived factor has been reported
to improve insulin sensitivity in skeletal muscle and liver
[15–17] resulting in stimulation of glucose utilization and
fatty acid oxidation [18], enhancement of glucose uptake
through the increment of expression and translocation of
GLUT4 [19], suppression of gluconeogenesis in the liver [20]
andenhancementofinsulinsignalinginskeletalmuscle[21].
Ficus deltoidea, from the Moraceae family, is one of the
common medicinal plants in Malaysia. It has been used
to relieve headache, fever, and toothache. Decoction of the
whole plant has been used as herbal drink by women after2 Evidence-Based Complementary and Alternative Medicine
birth to strengthen the uterus [22, 23]. Based on ethnob-
otanical approaches, this plant has been claimed to have
antidiabetic properties [22]. Few scientiﬁc studies were done
and conﬁrmed the antidiabetic activity of this plant. Acute
treatment of F. deltoidea extracts reduced hyperglycemia in
normal and diabetic rats at diﬀerent prandial states [24–
26]. Following 15-day treatment, hot aqueous extract of
F. deltoidea stimulated insulin release and reduced fasting
hyperglycemia [27]. Elucidation of antihyperglycemic mech-
anisms demonstrated that this plant enhanced basal and
insulin-stimulated glucose uptake into liver cells [28]a n d
reduced the rate of glucose absorption from small intestine
by inhibiting intestine sucrase activity [29]. The present
study was performed to ﬁnd other possible antidiabetic
mechanisms of F. deltoidea, if any, by evaluating the potential
of this plant to stimulate insulin secretion from pancreatic β
cells, to enhance glucose uptake into adipocyte cells, and to
augment adiponectin secretion from adipocyte cells.
2.Methodology
2.1. Chemicals and Reagents. BRIN BD11 cell line was a
gift from the Animal Cell Culture Laboratory, Faculty of
Biotechnology and Biomolecular Sciences, Universiti Putra
Malaysia. 3T3F442A preadipocytes were purchased from the
European Collection of Cell Cultures (ECACC, Salisbury,
UK). All cell culture supplements were purchased from
Invitrogen, USA. Ethanol and methanol were purchased
from J. T. Baker Chemical Co. Sodium chloride (NaCl), po-
tassium chloride (KCl), calcium chloride (CaCl2), potassium
dihydrogen phosphate (KH2PO4), magnesium sulphate
(MgSO4), sodium hydrogen carbonate (NaHCO3), HEPES,
sodium dodecyl sulphate (SDS), 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazoliumbromide(MTT),bovineinsulin,
ammonium hydroxide (NH4OH), dimethylsulphoxide
(DMSO), glibenclamide, isobutylmethylxanthine (IBMX),
tolbutamide, diazoxide, verapamil, and D-glucose were
purchased from Sigma Chemical Co. (St. Louise, MO, USA).
Ultima Gold LLT was purchased from PerkinElmer (USA).
2-Deoxy-[1-3H]-glucose was purchased from GE Healthcare
(USA). Rosiglitazone maleate (Avandia) was purchased from
a local pharmacy.
2.2. Plant Materials and Extraction Procedure. Plants of F.
deltoideawerecollectedattheSungaiTengiSelatan,Selangor,
Malaysia. The plants were identiﬁed by a taxonomist from
the Biodiversity Unit of the Institute of Bioscience, Universiti
Putra Malaysia. A specimen (SK1467/07) was deposited
at the herbarium of the above institute. The leaves of F.
deltoidea were oven dried at 45◦C and ground to a ﬁne
powder. Hot aqueous extracts were prepared by boiling the
powdered sample in distilled water for 3 hours (100g/L) by
changing the water every hour. The combined suspension
was ﬁltered using Whatman ﬁlter paper no. 54 and freeze-
dried to give the powdered form. Ethanolic extract was
prepared by soaking the powder in 95% ethanol for 3 days
(100g/L) at room temperature by changing solvent daily.
The combined suspension was ﬁltered using Whatman ﬁlter
paper no. 54 and evaporated to dryness under pressure at
30◦C to give an ethanolic extract. Methanolic extract was
prepared by soaking the powder in 95% methanol for 3 days
(100g/L) at room temperature by changing solvent daily.
The combined suspension was ﬁltered using Whatman ﬁlter
paper no. 54 and evaporated to dryness under pressure at
30◦Ctogiveamethanolicextract.Theyieldoftheextractwas
found to be 21g, 17g, and 19g for hot aqueous, ethanolic,
and methanolic extract, respectively.
2.3. Cell Viability Assay. The viability of all cell lines in the
presence of F. deltoidea hot aqueous, ethanolic, and meth-
anolic extracts was conducted according to the method of
Mosmann [30] and Carmichael et al. [31]. BRIN BD11
cell line was maintained in the Roswell Park Memorial
Institute(RPMI)1640mediumand3T3F442Apreadipocytes
were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM). Complete culture medium was supplemented
with 10% (v/v) foetal bovine serum (FBS) and 1%
(v/v) antibiotic solution (10,000 units/mL penicillin and
10mg/mL streptomycin) at 37◦C humidiﬁed with 5% CO2.
The conﬂuent cells were seeded at concentration of 1.5 ×
105 cells/well onto a sterile 96-well plate and incu-
bated at 37◦C overnight. Cells were further incubated
at 37◦C for 72 hours in the absence or presence of
F. deltoidea extracts (10–1000μg/mL) and glibenclam-
ide (10–2000μM). Following the required incubation
period, 20μL of 5mg/mL of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) was added to each
wellandincubatedfor4hours.Subsequently,themediafrom
each well was then gently aspirated and 100μL of dimethyl-
sulphoxide (DMSO) was added to dissolve the formazan
crystals. Plates were shaken for 5 seconds, and absorbance
was measured at 570nm using the Anthos microplate reader
(Beckman Coulter, USA).
2.4. Insulin Secretion Assay. Insulin secreting activity of F.
deltoidea was evaluated using BRIN-BD11 cells. The gen-
eration and basic characteristics of this glucose-responsive
insulin-secretingcelllinehavebeendescribedelsewhere[32].
BRIN BD11 cell line was maintained in RPMI 1640 medium
supplemented with 10% (v/v) FBS and 1% (v/v) antibiotic
solution (10,000 units/mL penicillin and 10mg/mL strepto-
mycin) at 37◦C humidiﬁed with 5% CO2. Insulin secretion
assay was conducted according to the method of Gray and
Flatt [33] with brief modiﬁcations. Cells were seeded at a
concentration of 2.5 × 105 cells/well in a 12-well plate and
incubated at 37◦C overnight to allow attachment prior to
test. The next day, cells were washed thrice with the Krebs-
Ringer bicarbonate buﬀer (KRB) and preincubated with this
KRB for 40 minutes at 37◦C. Cells were further incubated for
1 hours with KRB (negative control) KRB containing F. del-
toidea hot aqueous, ethanolic, and methanolic extracts (10–
1000μg/mL) KRB containing glibenclamide (10–2000μM).
All evaluations were performed at 2mM glucose. Insulin
concentration was determined using Rat Insulin ELISA Kits
(Mercodia AB, Sweden).Evidence-Based Complementary and Alternative Medicine 3
2.5. Elucidation of Insulin Secretion Mechanisms. F. deltoidea
extracts that showed tremendous insulin secretion activity
were further evaluated for determination of their insulin
secretory mechanisms. The evaluations were conducted
according to the method of Hannan et al. [34]. Extracts
were incubated with modulators that are known to aﬀect
secondary messenger pathway in pancreatic β-cells such as
insulin secretagogue (isobutylmethylxanthine (IBMX) and
tolbutamide), insulin secretion inhibitor (diazoxide and
verapamil), and potassium chloride (KCl) at depolarizing
concentration. Cells were seeded at a concentration of 2.5 ×
105 cells/well in a 12-well plates and incubated overnight at
37◦C to allow attachment prior to test. The next day, cells
were washed thrice with KRB and preincubated with KRB
for 40 minutes at 37◦C. Further incubation was done for 1
hour with KRB containing F. deltoidea extract in the absence
and presence of 100μM of IBMX, 200μM of tolbutamide,
300μM of diazoxide, 50mM of verapamil, and 30mM of
KCl.Allevaluationswereperformedat2mMglucose.Insulin
concentration was determined using Rat Insulin ELISA Kits
(Mercodia AB, Sweden).
2.6. Glucose Uptake Assay. 3T3F442A preadipocytes was
maintained in DMEM supplemented with 10% (v/v) FBS
and 1% (v/v) antibiotic solution (10,000 units/mL penicillin
and 10mg/mL streptomycin) at 37◦C humidiﬁed with 5%
CO2. The 3T3F442A preadipocytes were diﬀerentiated into
adipocytes spontaneously when reach conﬂuency. At this
time culture medium was supplemented with 5μg/mL
insulin. Glucose uptake assay was done according to Liu
et al. [35] with some modiﬁcations. Brieﬂy, conﬂuent cells
were seeded at a concentration of 2 × 105 cells/well in a 12-
well plate and left overnight at 37◦C to allow attachment
prior to test. The next day, cells were washed thrice with
serum-free DMEM and preincubated with this medium
for 2 hours at 37◦C. After starvation period, cells were
washed thrice with the Krebs-Ringer bicarbonate buﬀer
(KRB). Cells were further incubated for 30 minutes at 37◦C
with various concentrations of F. deltoidea extracts (10–
1000μg/mL) either alone or in combination with 100nM
insulin. Rosiglitazone maleate (Avandia) was used as positive
control. To initiate glucose uptake reaction, 2-deoxy-[1-3H]-
glucose (1μCi/mL) diluted in 0.1mM D-glucose solution
was added to each well and incubated further for 60 minutes
at 37◦C. After incubation, cells were washed thrice with
ice-cold KRB buﬀer and solubilized with 0.1% sodium
deodecyl sulphate (SDS) dissolved in phosphate buﬀer, pH
7.4.Thecontentofeachwellwastransferredintoscintillation
vials, and 15mL of scintillation cocktail, Ultima Gold LLT,
was added. The radioactivity incorporated into the cells
was measured using liquid scintillation counter (Hewlett
Packard, USA).
2.7. Adiponectin Secretion Assay. The potential of F. del-
toidea to stimulate adiponectin secretion was evaluated in
3T3F442A adipocyte cells. Adiponectin secretion assay was
conducted according to the method of Roﬀey et al. [36],
with brief modiﬁcations. Conﬂuent cells were seeded at
a concentration of 2 × 105 cells/well in 12-well plate and
left overnight at 37◦C humidiﬁed with 5% CO2 to allow
attachment prior to test. The next day, cells were washed
thrice with serum-free DMEM and pre-incubated with this
medium for 2 hours at 37◦C. After starvation period, cells
were washed thrice with the Krebs-Ringer bicarbonate buﬀer
(KRB). Cells were further incubated for 60 minutes at 37◦C
with various concentrations of F. deltoidea extracts (10–
1000μg/mL) either alone or in combination with 100nM
insulin. Rosiglitazone maleate was used as positive controls.
Adiponectin secreted in the solution was measured using Rat
Adiponectin ELISA Assay Kits (BioVision, USA).
2.8. Statistical Analysis. Results are expressed as mean ±
standard deviation for a given number of observations.
Statistical analyses were performed using GraphPad Prism
Software version 4.0 (serial no. GpW4-015977-RHB-3678).
The data were analyzed using one-way analysis of variance
(ANOVA), followed by Tukey’s post hoc test. The group
means were considered signiﬁcantly diﬀerent at the level of
P<0.05.
3. Results
3.1. Cells Viability in the Presence of F. deltoidea Extracts. The
eﬀects of F. deltoidea extracts and glibenclamide on BRIN
BD11 cell viability are shown in Table 1.A l le x t r a c t s ’a n d
glibenclamide, at particular, concentrations reduced BRIN
BD11 cells viability signiﬁcantly. Ethanolic and methanolic
extracts at concentrations of 500 and 1000μg/mL as well
as glibenclamide at concentration of 2000μM reduced the
viability of BRIN BD11 cells to less than 50%. In 3T3F442A
adipocytes, all F. deltoidea extracts reduced cell viability
signiﬁcantly at all concentrations evaluated (Table 2). How-
ever, no extract reduced cell viability to less than 50%.
Rosiglitazonemaleateexhibitedareductionincellviabilityat
concentration 7 to 140μM, and it was shown that reduction
at the highest concentration was more than 50%.
3.2. Insulin Secreting Activity of F. deltoidea Extracts. Eﬀects
ofF.deltoideaextractsandglibenclamideoninsulinsecretion
from BRIN BD11 cells are shown in Figure 1. Hot aqueous
extract exhibited a stepwise stimulatory eﬀect on insulin
secretion at 2mM glucose. Signiﬁcant stimulation was
observed at concentrations 50, 100, 500, and 1000μg/mL
which evoked a 2.61-(P<0.001), 3.68-(P<0.001), 4.38-
(P<0.001) and 7.31-(P<0.001) fold of stimulation,
respectively, compared to control. In the presence of ethano-
lic extract, a signiﬁcant stimulation of insulin secretion
(1.27-fold; P<0.001) was only observed at concentration
100μg/mL. Meanwhile, the methanolic extract signiﬁcantly
stimulated insulin secretion at all concentrations evaluated
with the magnitude of insulin secretion 1.24-fold (P<
0.001), 1.41-fold (P<0.001), 1.34-fold (P<0.001), 1.36-
fold (P<0.001), and 1.36-fold (P<0.001) obtained at con-
centrations of 10, 50, 100, 500, and 1000μg/mL, respectively.
Glibenclamide had signiﬁcantly stimulated insulin secretion
at concentrations of 1000μM (1.80-fold; P<0.001) and4 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀect of F. deltoidea extracts and glibenclamide on BRIN BD11 viability.
F. deltoidea
extracts
Cell viability (%)
Control 10μg/mL 50μg/mL 100μg/mL 500μg/mL 1000μg/mL
Hot aqueous 100.00 ±2.62 95.30 ±4.37 95.54 ±4.98 95.66 ±10.19 99.27 ±6.19 91.29 ±2.69
(8.71%)∗
Ethanolic 100.00 ±4.84 92.80 ±1.54∗∗∗
(7.20%)
89.60 ±3.30∗∗∗
(10.40%)
85.73 ±1.56∗∗∗
(14.27%)
38.88 ±0.94∗∗∗
(61.12%)
36.46 ±1.21∗∗∗
(63.54%)
Methanolic 100.00 ±6.38 99.32 ±3.39 97.42 ±5.62 101.38 ±2.79 41.80 ±2.62∗∗∗
(58.20%)
34.42 ±0.75∗∗∗
(65.58%)
Control 10μM 100μM 200μM 1000μM 2000μM
Glibenclamide 100.00 ±7.24 95.12 ±7.33 97.46 ±7.79 97.96 ±9.03 59.51±12.76∗∗∗
(40.49%)
32.71 ±2.79∗∗∗
(67.29%)
Notes: Cells were incubated for 72 hours in the presence of various concentrations of F. deltoidea extracts (10–1000μg/mL) and glibenclamide (10–2000μM).
Values are expressed as means ± standard deviations (n = 8) of percentage of cell viability from three independent assays. ∗P<0.05; ∗∗∗P<0.001 compared
with control. Values between brackets indicate the percentage of cell viability reduction.
Table 2: Eﬀect of F. deltoidea extracts and rosiglitazone maleate on 3T3F442A adipocyte viability.
F. deltoidea
extracts
Cell viability (%)
Control 10μg/mL 50μg/mL 100μg/mL 500μg/mL 1000μg/mL
Hot aqueous 100.00 ±9.42 90.75 ±14.33∗∗
(9.25%)
70.59 ±4.23∗∗∗
(29.41%)
66.25 ±2.52∗∗∗
(33.75%)
55.26 ±3.51∗∗∗
(44.74%)
55.03 ±1.51∗∗∗
(44.97%)
Ethanolic 100.00 ±1.10 86.92 ±3.14∗∗∗
(13.08%)
72.93 ±1.34∗∗∗
(27.07%)
69.60 ±1.56∗∗∗
(30.40%)
51.06 ±0.60∗∗∗
(48.94%)
55.07 ±6.14∗∗∗
(44.93%)
Methanolic 100.00 ±1.10 88.65 ±3.42∗∗∗
(11.35%)
72.54 ±1.45∗∗∗
(27.46%)
70.99 ±1.65∗∗∗
(29.01%)
62.61 ±4.01∗∗∗
(37.39%)
51.55 ±1.00∗∗∗
(48.45%)
Control 3.5μM7 μM3 5 μM7 0 μM 140μM
Rosiglitazone
maleate 100.00 ±7.05 91.57 ±6.58 77.10 ±7.31∗∗∗
(22.90%)
71.97 ±6.53∗∗∗
(28.03%)
54.01 ±7.41∗∗∗
(45.99%)
49.51 ±5.74∗∗∗
(50.49%)
Notes: Cells were incubated for 72 hours in the presence of various concentrations of F. deltoidea extracts (10–1000μg/mL) and rosiglitazone maleate (3.5–
140μM). Values expressed as percentage of means ± standard deviations (n = 8) of the cells viability from three independent assays. ∗∗P<0.01; ∗∗∗P<
0.001 compared with control. Values between brackets indicate percentage of cell viability reduction.
2000μM (1.73-fold; P<0.001). The former concentration
was used as standard reference because it shows the highest
magnitude of stimulation following a dose-response evalua-
tion.
3.3. Insulin Secretion Mechanisms of Hot Aqueous Extract.
The inﬂuence of insulin secretion modulators on the eﬀect
of 1000μg/mL hot aqueous extract on insulin secretion from
BRIN BD11 cells is shown in Figure 2.A l le v a l u a t i o n sw e r e
done at basal glucose concentration (2mM). It was shown
that 1000μg/mL of hot aqueous extract signiﬁcantly stim-
ulated basal insulin secretion (untreated control) by 5.57-
fold (P<0.001). All modulators showed no eﬀect on basal
insulin secretion except 30mM KCl which stimulated basal
insulin secretion by 3.60-fold (P<0.001). Insulin-releasing
eﬀect of 1000μg/mL of hot aqueous was potentiated in
the presence of all modulators except for 50mM verapamil
which exhibited similar magnitude of secretion between the
absence and presence of 1000μg/mL of hot aqueous extract.
The magnitudes of potentiation were 3.04-fold (P<0.001),
6.30-fold (P<0.001), 3.95-fold (P<0.001), and 2.60-
fold (P<0.001) in the presence of 30mM of KCl, 200μM
of tolbutamide, 100μM of IBMX, and 300μM of diazoxide,
respectively. Combinations of 1000μg/mL of hot aqueous
extract with 30mM KCl and tolbutamide had escalated the
insulin-releasing eﬀect of the extract when compared to the
extract alone. The magnitude of escalations were 1.96-fold
(P<0.001) and 1.56-fold (P<0.001), respectively. In
contrast,combinationsof1000μg/mLofhotaqueousextract
with diazoxide and verapamil had inhibited insulin-releasing
eﬀect of the extract with magnitudes of inhibition 0.49-
fold (P<0.001) and 0.79-fold (P<0.001), respectively.
Meanwhile the IBMX has no eﬀect on insulin secretion
causes by 1000μg/mL of hot aqueous extract.
3.4. Glucose Uptake Activity of F. deltoidea Extracts. Table 3
shows the eﬀects of F. deltoidea extracts on glucose uptake
activity in 3T3F442A adipocytes. Insulin (100nM) alone
enhanced glucose uptake by 1.55-fold (P<0.001) relative
to control. Hot aqueous extract has no eﬀect on glucose
uptake activity in 3T3F442A adipocytes. Ethanolic extract
increased basal and insulin-mediated glucose uptake in
a concentration-dependent manner. Basal glucose uptake
was enhanced at concentrations of 500, and 1000μg/mL.
Enhancement eﬀect produced by the later concentration was
1.32-fold (P<0.01) higher than that of 100nM insulin
alone. Insulin-mediated glucose uptake was enhanced at
concentrations of 100, 500, and 1000μg/mL. EnhancementEvidence-Based Complementary and Alternative Medicine 5
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Figure 1:EﬀectofF.deltoideaextractsandglibenclamideoninsulinsecretionactivityfromBRINBD11cells.Valuesareexpressedasmean ±
standard deviation (n = 4t o8 ) .∗∗P<0.01 and ∗∗∗P<0.01 compared with control.
eﬀect produced by the highest concentration was 1.29-
fold (P<0.05) higher than that of 100nM insulin. The
methanolic extract also exhibited concentration-dependent
enhancement of glucose uptake. Basal uptake was signiﬁ-
cantly enhanced at concentrations of 500 and 1000μg/mL.
The enhancement by the latter concentration was 1.27-fold
(P<0.05) higher than that of 100nM insulin alone. Insulin-
mediated uptake was signiﬁcantly enhanced at concentra-
tions of 100, 500, and 1000μg/mL. Rosiglitazone maleate
at concentrations of 35μMa n d7 0μM was used as positive
control to challenge the eﬀects of F. deltoidea on basal and
insulin-mediated glucose uptake in 3T3F442A adipocytes,
respectively. These concentrations were chosen because they
shows highest magnitude of enhancement following a dose-
response evaluation.
3.5. Adiponectin Secreting Activity of F. deltoidea Extracts.
Table 4 shows the eﬀect of F. deltoidea extracts on adiponect-
in secretion from 3T3F442A adipocytes. 100nM insulin
stimulatedadiponectinsecretionby1.64-foldrelativetocon-
trol. Hot aqueous extract augmented adiponectin secretion
in a concentration-dependent manner. Basal adiponectin
secretion was signiﬁcantly increased at concentrations of 500
and 1000μg/mL, respectively. Increments of adiponectin
secretion by such concentrations were 1.26-fold (P<0.001)
and 1.56-fold (P<0.001) higher than that of 100nM insulin
alone, respectively. Likewise, insulin-stimulated adiponectin
secretion was signiﬁcantly increased at concentrations of
500 and 1000μg/mL. The increment eﬀect by the latter
concentration was 1.27-fold higher than that of 100nM
insulin alone. For both concentrations of the extracts, there
were no diﬀerences in adiponectin secretion between basal
and insulin-stimulated state. Meanwhile, the ethanolic
extract of F. deltoidea has no eﬀect on adiponectin secretion
from 3T3F442A adipocytes. Similar to hot aqueous extract,
the methanolic extract increased adiponectin secretion
in a concentration-dependent manner. Basal adiponectin
secretionwassigniﬁcantlyincreasedatconcentrationsof500,
and 1000μg/mL. Under insulin-stimulated state, methanolic
extract at concentrations of 10, 50, 100, 500 and 1000μg/mL
increased adiponectin secretion. Rosiglitazone maleate at
concentrations of 70μMa n d3 5 μM was used as positive
controls to challenge eﬀect of F. deltoidea extracts on basal
and insulin-stimulated adiponectin secretion, respectively.
These concentrations were chosen because they produces the
highest stimulation eﬀect after a dose response evaluation.
The enhancement of adiponectin secretion by F. deltoidea
hot aqueous and methanolic extracts was lesser than that of
the positive controls.6 Evidence-Based Complementary and Alternative Medicine
Table 3: Eﬀect of F. deltoidea extracts on glucose uptake in 3T3F442A adipocytes.
Fold of glucose uptake against control
Extract
concentration
(μg/mL)
Control 100nM
insulin
Hot aqueous Ethanolic Methanolic Rosiglitazone malate
Basal Insulin-
mediated Basal Insulin-
mediated Basal Insulin-
mediated Basal Insulin-
mediated
10 0.88 1.00 1.11 1.24 1.02 1.16
35m
1.99∗∗∗
70μM
2.27∗∗∗
50 0.86 0.92 1.14 1.22 1.15 1.18
100 1.00 1.55∗∗∗ 1.13 1.45 1.18 1.35∗ 1.32 1.25∗
500 1.49 1.29 1.61∗∗∗ 1.69∗∗∗ 1.71 ∗∗∗ 1.54∗∗∗
1000 1.28 1.32 2.04∗∗∗
••
1.99∗∗∗
•
1.97∗∗∗
• 1.68∗∗∗
Values expressed as means ± standard deviations from three independent experiments.
∗P < 0.05, ∗∗∗P < 0.001 compared with control incubation.
•P<0.05, ••P<0.01 compared to 100nM insulin.
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Figure 2: The inﬂuence of insulin secretion modulators on the
eﬀect of 1000μg/mL hot aqueous extract on insulin secretion
from BRIN BD11 cells. Values are expressed as mean ± standard
deviation(n = 4). ∗∗∗P<0.001comparedwithincubationwithout
hot aqueous extract in the respective treatment group. •••P<0.001
compared with control treated with hot aqueous extract. ΨP<0.05;
ΨΨP<0.01 compared with untreated control.
4. Discussions
The present study reports for the ﬁrst time the insulin secret-
ing, glucose uptake, and adiponectin secretion properties
of F. deltoidea plant. These suggests that there is possibility
of presence of antidiabetic compounds in the F. deltoidea
plant which exert antidiabetic action through stimulation
of insulin secretion from pancreatic β cells, enhancement
of glucose uptake by adipocytes cells, and stimulation of
adiponectin secretion in adipocytes cells. Previous research
had reported that ﬂavonoids stimulated insulin secretion
from pancreatic β cells [37], stimulated adiponectin secre-
tion in adipocytes cells [16], and enhanced glucose uptake
into adipocytes cells in an insulin-mimetic manner [38]. In
addition, Eucalyptus globules plants which possess insulin
secreting activity have been reported to contain ﬂavonoids
and tannins [39]. Phytochemical screening of F. deltoidea
revealed the presence of high amount of ﬂavonoids and
tannins [40]. Thus, there is possibility that these secondary
metabolites account for the observed pharmacologic eﬀects
of the F. deltoidea plant.
The viability of BRIN BD11 cell in the presence of F.
deltoidea extracts at various concentrations was evaluated
using MTT assay. In this assay, the yellow tetrazolium salt,
MTT, is reduced by the mitochondrial enzymes, succinate
dehydrogenase, to form insoluble purple formazan crystals
which are solubilized by the addition of a detergent [30].
The color produced then can be measured spectrophoto-
metrically at 570nm [31]. MTT reduction was proportional
to cell viability [30]. Following 72-hour treatment, all
extracts at particular concentrations reduced BRIN BD11
and 3T3F442A adipocyte cells signiﬁcantly. According to
Elmore et al. [41], the highest concentration of a test agent in
cytotoxicity evaluation should be 1000μg/mL or 1000μM. If
none of the concentrations of test agents exhibited cytotoxic
eﬀect in excess of 50% of cell populations, the test agent is
considerednontoxicagainstthetestedcellline.Inthepresent
study, ethanolic and methanolic extracts at concentrations of
500 and 1000μg/mL reduce the viability of BRIN BD11 cells
to less than 50%. Thus, both extracts were considered toxic
against BRIN BD11 cells [41].
Insulin is an anabolic hormone secreted by pancreatic
β cells in response to elevation of blood glucose concen-
tration especially after meal [42, 43]. This hormone main-
tains body glucose homeostasis by regulating metabolism
of carbohydrate, lipid, and protein [44]. Insulin reduced
hyperglycemia by facilitating glucose disposal from blood
circulation into insulin-responsive cells such as muscle,
adipose, and liver [45, 46]. The secretion of insulin involved
twomajorsignalingpathways,K+
ATP channel-dependentand
K+
ATP channel-independent pathways [42, 47]. The former
is responsible for the ﬁrst-phase glucose-stimulated insulin
secretion whereas combination of both pathways responsibleEvidence-Based Complementary and Alternative Medicine 7
Table 4: Eﬀect of F. deltoidea extracts on adiponectin secretion from 3T3F442A adipocytes.
Fold of glucose uptake against control
Extract
concentration
(μg/mL)
Control 100nM
insulin
Hot aqueous Ethanolic Methanolic Rosiglitazone malate
Basal Insulin-
mediated Basal Insulin-
mediated Basal Insulin-
mediated Basal Insulin-
mediated
10 1.01 0.93 1.06 0.99 1.11 1.45∗∗∗
70μM
3.10∗∗∗
•••
3.5μM
2.93∗∗∗
•••
50 1.16 1.05 0.99 1.04 1.09 1.46∗∗∗
100 1.00 1.64∗∗∗ 1.20 1.21 1.04 1.12 1.28 1.53∗∗∗
500 2.06∗∗∗
••• 1.48∗∗∗ 1.05 1.15 1.30∗ 1.67∗∗∗
1000 2.46∗∗∗
•••
2.10∗∗∗
••• 1.17 1.24 1.53∗∗∗ 1.70∗∗∗
Values expressed as means ± standard deviations from three independent experiments.
∗P < 0.05, ∗∗∗P < 0.001 compared with control incubation.
•••P<0.001 compared to 100nM insulin.
forsecond-phasesecretion[48].Theunderlyingmechanisms
involved in the K+
ATP channel-dependent pathway are well
deﬁned. In this pathway, glucose is transported into β cells
through facilitated diﬀusion of GLUT2 glucose transporters
and this glucose undergoes metabolism to produce ATP
molecules. The increase of intracellular ATP/ADP ratio
results in the closure of the K+
ATP channel and leads to
depolarization of the membrane. This causes the opening of
voltage-dependent calcium (Ca2+) channels and facilitating
extracellularCa2+ inﬂuxintotheβcell.Ariseinfreecytosolic
Ca2+ eventually activates an eﬀectors system responsible for
translocation of insulin-containing secretory granules to the
plasma membrane and the exocytotic release of insulin [43,
48]. Meanwhile, mechanisms underlying the K+
ATP channel-
independent pathway remain unclear. Two mechanisms have
been suggested; the enhancement of the stimulatory eﬀect
of Ca2+ on the secretory process [43] and the changes
of regulators of the K+
ATP channel-independent pathway,
adenine nucleotide concentration [42].
In the present study, hot aqueous extract of F. deltoidea
stimulates insulin secretion signiﬁcantly with the highest
magnitude of stimulation 7.31-fold (P<0.001) obtained at
concentration of 1000μg/mL. This stimulation was greater
than that of 1000μM glibenclamide. This suggests that F.
deltoidea may contain water-soluble insulin-secreting com-
pounds that are more potent than glibenclamide. Viability
study had conﬁrmed that hot aqueous extract did not
inﬂuence BRIN BD11 cells. These observations suggest that
the hot aqueous extract of F. deltoidea has the enormous
potential to be developed as new oral hypoglycemic agents
targeted on stimulation of insulin secretion. Ethanolic
extract (100μg/mL) and methanolic extract (all concentra-
tions) induced an increased insulin secretion. However, both
extracts were found toxic against BRIN BD11 cells. This
could possibly be due to the presence of toxic compounds in
bothextractswhichcandamagessubcellularorganellesofthe
cellsandleadtocelldeath[49].Thus,theeﬃcacyofethanolic
and methanolic extracts in stimulating insulin secretion may
not be taken into account.
The 1000μg/mL of hot aqueous extract was further
evaluated for determination of mechanisms underlying its
insulin secretory action. This concentration of extract was
chosen because it possesses the highest insulin secretion
property among all F. deltoidea extracts. The extract was
incubated in the presence and absence of insulin secretion
modulators such as the insulinotropic agonist (tolbutamide
and IBMX), insulinotropic antagonist (diazoxide and vera-
pamil), and depolarization concentration of KCl (30mM). It
wasshownthat30mMKClstimulatedbasalinsulinsecretion
whereas other modulators did not. This could possibly
be due to that 30mM KCl fully depolarized the plasma
membrane, hence activate Ca2+ channel and trigger insulin
release [50, 51] .T o l b u t a m i d e ,ah y p o g l y c e m i ca g e n tf r o m
sulphonylureas group, stimulated insulin release through
K+
ATP channel-dependent pathway [43, 52, 53]. This drug
acts by closing K+
ATP channel, depolarizing the plasma
membrane, and stimulating the inﬂux of Ca2+ through the
activation of voltage-dependent calcium channels [54, 55].
In this study, tolbutamide had augmented insulin-releasing
eﬀect of 1000μg/mL of hot aqueous extract indicating that
insulin-secretory action of the 1000μg/mL of hot aqueous
extract involved K+
ATP channel-dependent pathway [34].
IBMX,aninhibitorofphosphodiesterase,raisedintracellular
cAMP levels of pancreatic β cells and enhanced insulin
secretion at nonstimulatory glucose concentration [56].
In this study, IBMX did not potentiate insulin releasing
eﬀect of 1000μg/mL of hot aqueous extract suggesting that
insulin secretory action of the extract did not involve cAMP
production [57], and thus it was not mediated through
cAMP-activated pathway such as protein kinase A (PKA)
pathway [58].
Diazoxide, an established opener of K+
ATP channels,
inhibited insulin release through activation (opening) of the
K+
ATP channels of the β cells [43, 51, 59]. In this study,
diazoxide had signiﬁcantly inhibited insulin-releasing eﬀects
of 1000μg/mL of hot aqueous extract, indicating that acti-
vation of K+
ATP channel participated in the insulin secretory
action of the extract. This observation again suggested that8 Evidence-Based Complementary and Alternative Medicine
K+
ATP channel-dependent pathway is involved in the insulin
secretory action of the extract. It was shown that diazoxide
inhibitedbutdidnotcompletelyabolishtheinsulin-releasing
eﬀects of 1000μg/mL hot aqueous extract. This suggested
that, beside K+
ATP channel-dependent pathway, the stimula-
tory action of the 1000μg/mL of hot aqueous extract might
also involve K+
ATP channel-independent pathway [60]. This
suggestion was supported by observation with 30mM KCl,
a concentration that fully depolarized the cell membrane.
Further potentiation of insulin release by 1000μg/mL of
hot aqueous extract under depolarized condition indicat-
ing that the extract also exerts insulin-secreting action
through K+
ATP channel-independent manner [50, 51]. In
this study, the molecular mechanisms underlying K+
ATP
channel-independent pathway were not evaluated. It was
reported that, under K+
ATP channel-independent pathway,
insulin release was triggered through the enhancement of the
stimulatory eﬀect of Ca2+ on the secretory process [43]o r
changes adenine nucleotide concentration [42]. Verapamil is
an L-type voltage-dependent Ca2+ channel (VDCC) blocker
from phenylalkylamine classes. This drug inhibited insulin
release by preventing Ca2+ inﬂux into the cells through L-
type VDCC [61]. In this study, verapamil had signiﬁcantly
inhibited the insulin-releasing eﬀects of 1000μg/mL hot
aqueous extract indicating that the insulin secretory action
of the extract was dependent on extracellular Ca2+ that is
acquired through activation of VDCC. It was shown that
verapamil only inhibited but did not completely abolish
insulin-releasing eﬀects of 1000μg/mL hot aqueous extract
from BRIN BD11 cells indicating that insulin release also
occurs in the absence of extracellular Ca2+. This suggests that
the extract may have the ability to induce mobilization of
stored intracellular Ca2+ to promote insulin release [34]. The
other possible mechanism for ability of the extract to trigger
insulin release in the presence of verapamil is the inﬂux of
Ca2+ occuring through other types of Ca2+ channel such
as N-type Ca2+ channel and voltage-operated Ca2+ channel
(VOCC), thereby increased intracellular concentration of
Ca2+ [62–64]. In this study, the eﬀect of F. deltoidea extracts
on insulin secretion was evaluated at basal glucose con-
centration (2mM) only, and no evaluation at high glucose
concentration (16.7mM) was performed. So, it could not
be concluded that insulin-secreting activity of F. deltoidea
extracts is glucose-dependent. It was widely accepted that a
good insulinotropic agent must be able to stimulate insulin
secretion at both basal and elevated glucose concentrations
[65].
Insulin was reported to increase glucose uptake in
adipocytes cells [35, 66, 67]. The present study was in accord
with such reports that 100nM insulin signiﬁcantly increased
glucose uptake by approximately 1.64-fold in 3T3F442A
adipocyte cells. The same concentration of insulin was also
used to stimulate glucose uptake in the presence of F.
deltoidea extracts. This concentration of insulin was widely
used to stimulate glucose uptake into adipocytes cells [68,
69]. In the present study, ethanolic (500 and 1000μg/mL)
and methanolic extracts (500 and 1000μg/mL) signiﬁcantly
enhance basal (absence of 100nM insulin) glucose uptake.
The enhancement of both extracts at concentration of
1000μg/mL was signiﬁcantly higher than that of 100nM
insulin alone indicating that such concentration of extracts
enhances glucose uptake in an insulin-mimetic manner.
Meanwhile, both extracts at concentrations of 100, 500, and
1000μg/mL signiﬁcantly enhance insulin-stimulated (pres-
ence of 100nM insulin) glucose uptake. It was shown that
enhancement of 1000μg/mL of ethanolic extract was signiﬁ-
cantly higher than that of 100nM insulin indicating that the
extract enhances glucose uptake by sensitizing insulin action
[70, 71]. It was shown that 1000μg/mL of ethanolic extract
enhances glucose uptake by both mimicking and sensitizing
insulin action. Many antidiabietic plants enhanced glucose
uptake through the above mechanisms, for example, Lager-
stroemia speciosa [35]a n dAgaricus campestris [33]h a v eb e e n
reported to enhance glucose uptake in an insulin-mimetic
manner, Salvia miltiorrhiza Bunge [72] through insulin-
sensitizing mechanisms, and Campsis grandiﬂora [73]a n d
Vaccinium angustifolium [67] through both mechanisms.
Rosiglitazone maleate at concentrations of 35μM (1.99-
fold) and 70μM (2.27-fold) were used as positive control
to challenge glucose uptake activity of F. deltoidea extracts
under basal and insulin-stimulated states, respectively. These
concentrations were chosen because they produced high-
est enhancement eﬀect after a dose-response evaluation.
Rosiglitazone is an antidiabetic drug from thiazolidinedione
(TZD) groups. This PPAR gamma agonist has been shown
to enhance glucose uptake into adipocytes cells [74]. In
this study, 1000μg/mL of ethanolic and methanolic extracts
which evoked an uptake of 2.04- and 1.97-fold, respectively
exhibitedacomparablepotentialofbasalglucoseuptakewith
35μM rosiglitazone maleate. Under insulin-stimulated state,
neither ethanolic extract nor methanolic extract exhibited
comparable potential of glucose uptake activity with 70μM
rosiglitazone maleate.
Beside stimulation of glucose uptake, insulin also was
reported to stimulate adiponectin secretion from adipocytes
cells [75, 76]. Treatment of adipocytes cells with 160nM
insulin increased adiponectin secretion by 2-fold [77]. In
the present study, 100nM insulin signiﬁcantly stimulates
adiponectin secretion from 3T3F442A adipocytes cells by
1.60-fold. The hot aqueous extract (500 and 1000μg/mL)
augmentsbasalandinsulin-stimulatedadiponectinsecretion
signiﬁcantly. It was found that basal secretion was higher
than the insulin-stimulated secretion, and this suggests
that adiponectin secretion activity of hot aqueous extract
was independent of insulin. The 500μg/mL of hot aque-
ous extract augments basal adiponectin secretion higher
than 100nM insulin indicating that the extract augments
adiponectin secretion in an insulin-mimetic manner [78].
Meanwhile, 1000μg/mL of hot aqueous extract augments
both basal and insulin-stimulated adiponectin secretion
greater than that of 100nM insulin suggesting that this
extract enhances adiponectin secretion by mimicking and
sensitizing insulin action. Methanolic extract at higher
concentrations (500 and 1000μg/mL) augments basal ad-
iponectin secretion signiﬁcantly whereas lower concentra-
tions(10,50,and100μg/mL)didnotaﬀectbasaladiponectin
secretion. Meanwhile, insulin-stimulated adiponectin secre-
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extract. Augmentation of adiponectin secretion by methano-
lic extract was lesser than that of 100nM insulin alone
suggesting that the extract did not mimic or sensitize insulin
action. Rosiglitazone maleate was used as positive control
to challenge F. deltoidea extracts in augmenting adiponectin
secretion from 3T3F442A adipocytes. TZD groups have been
found to increase expression and synthesis of adiponectin
in vitro and in vivo [79, 80]. In addition, treatment of
3T3-L1 adipocytes with TZDs increased adiponectin secre-
tion by 67–89% [79]. In this study, rosiglitazone maleate
increased basal and insulin-stimulated adiponectin secretion
by 3.10- and 2.93-fold, respectively. However, neither hot
aqueousnormethanolicextractsaugmentedbasalorinsulin-
stimulated adiponectin secretion to a greater extent than
that of rosiglitazone maleate indicating that potential of F.
deltoidea in augmenting adiponectin secretion was lesser
thanrosiglitazonemaleate.Thiscouldpossiblybeduetothat
such F. deltoidea extracts contain mixture of bioactive and
nonbioactive compounds, and there is possibility that the
non-bioactivewouldreducetheconcentrationofactivecom-
poundsintheextractanddecreasedtheabilityoftheextracts
to stimulate adiponectin secretion. In contrast, the potential
of rosiglitazone maleate which consists of single compound
to stimulate adiponectin secretion from adipocytes cells has
been scientiﬁcally proven [79].
This study had shown hot aqueous, ethanolic, and meth-
anolic extracts of F. deltoidea stimulates insulin secretion
from BRIN BD11 cells signiﬁcantly. Nevertheless, insulin-
secreting property of ethanolic and methanolic extracts
could not be considered because such extracts were found
toxic against BRIN BD11 cells. Mechanisms underlying
insulin secretory action of hot aqueous extract involve both
K+
ATP channel-dependent and independent pathways. The
extract also has the ability to induce the usage of intracellular
Ca2+ to trigger insulin release. The ethanolic and methanolic
extracts have the ability to enhance basal and insulin-
stimulated glucose uptake into adipocyte cells. The extracts
possess either insulin-mimetic or insulin-sensitizing prop-
erty or combination of both properties during enhancing
glucose uptake into such cells. Ethanolic extract exhibited
the higher potential of glucose uptake activity compared
to methanolic extract whereas the hot aqueous extract has
no eﬀect on glucose uptake activity. Meanwhile, the hot
aqueous and methanolic extracts augment basal and insulin-
stimulated adiponectin secretion from adipocyte cells. The
hot aqueous extract exhibited higher adiponectin secretion
activity as compared to methanolic extract whereas the
ethanolicextracthasnoeﬀectonadiponectinsecretionactiv-
ity.
In this study, it was shown that hot aqueous extract
exhibited signiﬁcant insulin secretion and adiponectin secre-
tionactivitybuthasnoeﬀectonglucoseuptakeactivitywhile
theethanolicextractshowedsigniﬁcantglucoseuptakeactiv-
ity but has no eﬀect on the former two activities. Meanwhile,
the methanolic extract exhibited signiﬁcant adiponectin
secretion and glucose uptake activity but not insulin secre-
tion activity. This could be due to the fact that each F.
deltoideaextractpossessesantidiabeticcompoundswhichare
unique for some activity only. For example, the hot aqueous
extract may own antidiabetic compounds that exert its an-
tidiabetic actions by stimulation of insulin secretion from
pancreatic β cells and augmentation of adiponectin secretion
from adipocytes cells while the ethanolic extract may own
antidiabetic compounds that exert its antidiabetic action by
enhancement of glucose uptake in adipocytes cells only.
5. Conclusions
From this study, it was suggested that the antihyperglycemic
actions of F. deltoidea are mediated through stimulation of
insulin secretion from pancreatic β cells, enhancement of
glucose uptake by adipocytes cells, and augmentation of
adiponectin secretion from adipocytes cells as well. The dual
pancreatic and extrapancreatic actions of F. deltoidea illus-
trate the enormous potential of this plant to be developed as
new oral antidiabetic drugs. Furthermore, the adiponectin-
secreting and insulin-sensitizing properties of F. deltoidea
indicated that this plant could ameliorate systemic insulin
resistance and may potentially be beneﬁcial for type 2
diabetes mellitus related to insulin resistance.
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